Stay updated with breaking news from Inspiremd inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. InspireMD Price Performance Shares of NYSE NSPR opened at $2.53 on Friday. The stock has a market capitalization of $63.07 million, a price-to-earnings ratio of -3.33 and a beta […] ....
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection. ....
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and InspireMD (NYSE:NSPR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Volatility and Risk LeMaitre Vascular has a beta […] ....
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and InspireMD (NYSE:NSPR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk. Insider & Institutional Ownership 84.6% of LeMaitre Vascular […] ....
InspireMD (NYSE:NSPR) Posts Earnings Results, Misses Estimates By $0.06 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.